A Randomized Phase III Study in Low Grade Lymphoma Comparing Maintenance Anti-CD20 Antibody versus Observation following Induction Therapy: A trial of the ECOG-ACRIN Cancer Research Group (E1496)

BACKGROUND: In the ECOG-ACRIN Cancer Research Group study, E1496, we reported that maintenance rituximab prolonged progression-free survival when compared to observation alone in patients with indolent lymphoma after induction chemotherapy. Here we present the long-term follow-up of the same patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Barta, Stefan K., Li, Hailun, Hochster, Howard S., Hong, Fangxin, Weller, Edie, Gascoyne, Randy D., Habermann, Thomas M., Gordon, Leo I., Colocci, Natalia, Bengtson, Elizabeth M, Horning, Sandra J., Kahl, Brad S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5030179/
https://ncbi.nlm.nih.gov/pubmed/27351685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30137
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados